The Global Animal Healthcare/Veterinary Market is expected to grow from USD 35,172.40 Million in 2019 to USD 46,782.31 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.86%

New York, July 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Animal Healthcare/Veterinary Market Research Report by Pharmaceuticals, by Vaccines, by Medical Feed Additives, by Animal Type - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913193/?utm_source=GNWOn the basis of Pharmaceuticals, the Animal Healthcare/Veterinary Market is studied across Anti Infalmmatories, Anti-Invectives, Ectoparaciticides, and Endoparaciticides.On the basis of Vaccines, the Animal Healthcare/Veterinary Market is studied across Cattle Vaccines, Companion Animal Vaccines, Equine Vaccines, Poultry Vaccines, and Swine Vaccines.On the basis of Medical Feed Additives, the Animal Healthcare/Veterinary Market is studied across Amino Acids, Antibiotics, Antioxidants, Feed enzymes, Minerals, Prebiotics and Probiotics, and Vitamins.On the basis of Animal Type, the Animal Healthcare/Veterinary Market is studied across Companion Animal and Farm Animal.On the basis of Geography, the Animal Healthcare/Veterinary Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United To keep reading about The Global Animal Healthcare/Veterinary Market is expected to grow from USD 35,172.40 Million in 2019 to USD 46,782.31 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.86%, Click on the link. Seoul, Korea
http://dlvr.it/RcLWHg

Comments

Post a Comment

Popular posts from this blog

New Philadelphia Digital Agency Makes Its Public Debut

Image
PHILADELPHIA, Aug. 26, 2020 /PRNewswire/ -- Moxie Labs, a digital marketing & product development agency located in Philadelphia, PA, is making its debut. The agency is co-founded by Justin Mathews (CEO) and Mike O'Malley (CIO), industry veterans who have spent the majority of their careers navigating the city's technology and marketing sectors.  O'Malley worked for prominent marketing agencies such as MedManage Systems & Aptus Health, and eventually went on to build out his own shop, Elevation Agency. Mathews went down a management and business development route in the Philadelphia technology industry and worked for a few local notables such as Refinery, Tonic Design, and most recently, O3 World. The two entrepreneurs had long been aware of the intersection of marketing and technology in the business world. When discussing the possibility of starting a new business venture, they decided to build a new agency that recognized the importance of both niches for modern ...
Read more

US intel chief rebukes lawmakers over 'pandemic' of leaks

Image
WASHINGTON (AFP) - US intelligence chief John Ratcliffe on Sunday (Aug 30) defended his move to end in-person election security briefings to Congress, blaming a "pandemic" of leaks from lawmakers. The Director of National Intelligence wrote to top lawmakers from both parties in the House and Senate intelligence committees on Friday explaining the change. The announcement sparked accusations from senior Democrats that the administration was covering up Russian help for President Donald Trump's re-election bid. Ratcliffe voiced frustration over leaks from a counterintelligence briefing to Congress a month ago informing lawmakers that China, Russia and Iran were all seeking to interfere. "And yet, within minutes of that... a number of members of Congress went to a number of different publications and leaked classified information," Ratcliffe told Fox News. He said the leakers aimed to "create a narrative that simply isn't true, that somehow Russia is a gre...
Read more

New Data Suggest ExoFlo is Poised for a Quantum Leap in the Fight Against COVID-19

Image
AUSTIN, Texas, Aug. 27, 2020 /PRNewswire/ -- Direct Biologics, LLC announces a rapid acceleration of the investigational use of ExoFlo™ for treatment of COVID-19 as new mechanisms of SARS-CoV-2 have been revealed. Published in Lung Cellular and Molecular Physiology in August, a recent research collaboration by bioinformatics experts in the United States and Poland suggests that the SARS-CoV-2 viral genome may be binding to specific human microRNA (miRNA) in the manner of an epigenetic "sponge"— essentially inhibiting normal downstream processes and facilitating viral hijacking and/or immune evasion. "These findings are highly interesting and pertinent to our research," states Dr. Vik Sengupta, Chief Medical Officer, "especially since the authors' exomic analysis reveals the depletion of multiple miRNA targets. These data complement our recent findings that ExoFlo contains multiple miRNA that may specifically inhibit the SARS-CoV-2 viral invasion and modulat...
Read more